Cambridge Investment Research Advisors, Inc. Zoetis Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 61,800 shares of ZTS stock, worth $10.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

61,800

Previous 60,760 1.71%

Holding current value

$10.1 Million

Previous $10.5 Million 14.64%

% of portfolio

0.04%

Previous 0.04%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$172.58 - $196.48 $179,483 - $204,339	1,040 Added 1.71%	61,800 $12.1 Million
Q2 2024 Jul 26, 2024	SELL	$145.54 - $178.83 $912,390 - $1.12 Million	-6,269 Reduced 9.35%	60,760 $10.5 Million
Q1 2024 Apr 24, 2024	BUY	$165.67 - $199.94 $1.2 Million - $1.44 Million	7,217 Added 12.07%	67,029 $11.3 Million
Q4 2023 Feb 09, 2024	SELL	$151.44 - $200.09 $287,281 - $379,570	-1,897 Reduced 3.07%	59,812 $11.8 Million
Q3 2023 Oct 24, 2023	SELL	$167.14 - $192.77 $254,888 - $293,974	-1,525 Reduced 2.41%	61,709 $10.7 Million
Q2 2023 Jul 13, 2023	BUY	$160.94 - $186.23 $42,649 - $49,350	265 Added 0.42%	63,234 $10.9 Million
Q1 2023 May 11, 2023	SELL	$145.48 - $175.02 $991,300 - $1.19 Million	-6,814 Reduced 9.76%	62,969 $10.5 Million
Q4 2022 Feb 08, 2023	BUY	$131.14 - $157.47 $1.19 Million - $1.42 Million	9,040 Added 14.88%	69,783 $10.2 Million
Q3 2022 Oct 17, 2022	BUY	$148.29 - $182.55 $245,568 - $302,302	1,656 Added 2.8%	60,743 $9.01 Million
Q2 2022 Jul 13, 2022	BUY	$155.97 - $200.09 $702,488 - $901,205	4,504 Added 8.25%	59,087 $10.2 Million
Q1 2022 May 12, 2022	SELL	$181.39 - $234.03 $822,785 - $1.06 Million	-4,536 Reduced 7.67%	54,583 $10.3 Million
Q4 2021 Feb 03, 2022	BUY	$193.69 - $247.03 $635,303 - $810,258	3,280 Added 5.87%	59,119 $14.4 Million
Q3 2021 Nov 02, 2021	SELL	$189.29 - $209.69 $243,994 - $270,290	-1,289 Reduced 2.26%	55,839 $10.8 Million
Q2 2021 Aug 10, 2021	BUY	$155.9 - $187.99 $635,136 - $765,871	4,074 Added 7.68%	57,128 $10.6 Million
Q1 2021 May 07, 2021	BUY	$144.0 - $169.39 $944,640 - $1.11 Million	6,560 Added 14.11%	53,054 $8.35 Million
Q4 2020 Feb 04, 2021	SELL	$157.07 - $174.35 $614,457 - $682,057	-3,912 Reduced 7.76%	46,494 $7.69 Million
Q3 2020 Oct 29, 2020	BUY	$137.1 - $165.37 $586,925 - $707,948	4,281 Added 9.28%	50,406 $8.34 Million
Q2 2020 Jul 27, 2020	BUY	$111.92 - $142.53 $1.61 Million - $2.05 Million	14,378 Added 45.29%	46,125 $6.32 Million
Q1 2020 May 08, 2020	BUY	$92.66 - $144.94 $207,280 - $324,230	2,237 Added 7.58%	31,747 $3.74 Million
Q4 2019 Feb 04, 2020	BUY	$116.25 - $133.25 $247,263 - $283,422	2,127 Added 7.77%	29,510 $3.91 Million
Q3 2019 Nov 06, 2019	BUY	$112.57 - $128.43 $168,629 - $192,388	1,498 Added 5.79%	27,383 $3.41 Million
Q3 2019 Oct 28, 2019	SELL	$112.57 - $128.43 $7,204 - $8,219	-64 Reduced 0.25%	25,885 $3.23 Million
Q2 2019 Aug 15, 2019	BUY	$97.98 - $114.28 $152,652 - $178,048	1,558 Added 6.39%	25,949 $0
Q1 2019 May 08, 2019	BUY	$81.56 - $100.67 $191,095 - $235,869	2,343 Added 10.63%	24,391 $0
Q4 2018 Feb 05, 2019	BUY	$79.28 - $95.27 $215,562 - $259,039	2,719 Added 14.07%	22,048 $1.89 Million
Q3 2018 Nov 02, 2018	BUY	$83.5 - $93.23 $13,694 - $15,289	164 Added 0.86%	19,329 $0
Q2 2018 Aug 10, 2018	BUY	$79.9 - $89.2 $20,294 - $22,656	254 Added 1.34%	19,165 $0
Q1 2018 May 09, 2018	BUY	$71.51 - $84.69 $73,655 - $87,230	1,030 Added 5.76%	18,911 $0
Q4 2017 Feb 22, 2018	BUY	$63.24 - $72.8 $246,888 - $284,211	3,904 Added 27.93%	17,881 $0
Q3 2017 Nov 07, 2017	BUY	$59.73 - $65.4 $101,063 - $110,656	1,692 Added 13.77%	13,977 $891,000
Q2 2017 Aug 08, 2017	BUY	N/A	12,285	12,285 $766,000

Others Institutions Holding ZTS

# of Institutions

1,955

Shares Held

411M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Zoetis Inc. Transaction History